JP5102432B2 - Cancer cell dormant - Google Patents

Cancer cell dormant Download PDF

Info

Publication number
JP5102432B2
JP5102432B2 JP2004306087A JP2004306087A JP5102432B2 JP 5102432 B2 JP5102432 B2 JP 5102432B2 JP 2004306087 A JP2004306087 A JP 2004306087A JP 2004306087 A JP2004306087 A JP 2004306087A JP 5102432 B2 JP5102432 B2 JP 5102432B2
Authority
JP
Japan
Prior art keywords
white rice
active ingredient
rice
enzyme
cancer cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2004306087A
Other languages
Japanese (ja)
Other versions
JP2006117575A (en
Inventor
純夫 渡辺
孝 徳山
Original Assignee
株式会社創研
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 株式会社創研 filed Critical 株式会社創研
Priority to JP2004306087A priority Critical patent/JP5102432B2/en
Publication of JP2006117575A publication Critical patent/JP2006117575A/en
Application granted granted Critical
Publication of JP5102432B2 publication Critical patent/JP5102432B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Description

本発明は、米由来成分を有効成分とするがん細胞休眠剤(例えば大腸がん)及び大腸がん予防治療剤に関するものである。   The present invention relates to a cancer cell dormant (for example, colorectal cancer) and a colorectal cancer preventive or therapeutic agent comprising a rice-derived component as an active ingredient.

がんは日本人の死亡原因の約30%を占めており、がんの克服は国民的課題の一つである。現在行われている治療は、がんの切除、消滅を目的とするものであるが、進行状態によりその方法は異なる。   Cancer accounts for about 30% of Japanese causes of death, and overcoming cancer is a national issue. The current treatment is aimed at the removal and extinction of cancer, but the method varies depending on the progression.

進行がん、末期がん、治療後に再発、転移したがんに対しては、全身治療(抗がん剤治療)が行われている。しかしながら、これまでの抗がん剤は、がんに特異的に作用するものではなく、増殖の速い細胞に作用するものがほとんどであるため、正常細胞であっても骨髄や消化管粘膜、毛髪のように増殖の盛んな細胞は、抗がん剤の作用を受け、白血球減少、嘔吐、下痢、脱毛などの副作用を起こす。加えて、がんを消滅させる為には大量の抗がん剤を投与する必要があるため、全身が副作用に絶えうる状態でなければ、却って状態が悪化したり、寿命を縮めてしまうという結果を招く。また、投与量をコントロールし、がんの縮小に成功したとしても、ある程度の延命効果が期待できるに留まる。このように、現在、上記ステージに至ったがんを克服することができる有効な薬剤は存在せず、そのため、がんの進行、転移を阻止し、副作用がなく長期にわたって服用可能な薬剤が求められている。   Systemic treatment (anticancer drug treatment) is performed for advanced cancer, terminal cancer, and cancer that has recurred or metastasized after treatment. However, since conventional anticancer agents do not act specifically on cancer but mostly act on fast-growing cells, even normal cells can be bone marrow, digestive tract mucosa, hair Such proliferating cells are affected by anticancer drugs and cause side effects such as leucopenia, vomiting, diarrhea, and hair loss. In addition, since it is necessary to administer a large amount of anticancer drugs to eliminate the cancer, if the whole body is not in a state where it can be completely free from side effects, the condition worsens or the life span is shortened. Invite. Even if the dose is controlled and the cancer is successfully reduced, a certain degree of life-prolonging effect can be expected. Thus, there is currently no effective drug that can overcome the cancer that has reached the above stage. Therefore, there is a need for a drug that can prevent cancer progression and metastasis and can be taken for a long time without side effects. It has been.

一方、がんが早期の段階で発見され、限局している場合は、局所治療(外科治療、放射線治療)が行われるが、肉眼的には切除、消滅できてもリンパ節等への転移がある場合は再発する可能性が高いため、がん再発防止に有効な薬剤も求められている。   On the other hand, if cancer is detected at an early stage and is localized, local treatment (surgical treatment, radiotherapy) is performed, but metastasis to lymph nodes etc. is possible even if it can be excised and disappeared macroscopically. Since there is a high possibility of recurrence in some cases, there is a need for drugs that are effective in preventing cancer recurrence.

更に、がんの中でも大腸がんによる死亡例は、肺がん、胃がんに次いで3位になっており、近年増加傾向にある。大腸がんの原因としては、食習慣の欧風化に伴う、動物性脂肪の摂取量増加が指摘されている。また年齢別にみると、60歳代、50歳代、70歳代の順に多く、高齢者に多い傾向にある。今後、食生活の西欧化、高齢者の増加に伴い、大腸がんが益々増加することが予想される。   Furthermore, deaths from colorectal cancer among cancers are ranked third after lung cancer and stomach cancer, and have been increasing in recent years. As a cause of colorectal cancer, it has been pointed out that the intake of animal fat is increased due to the westernization of eating habits. In terms of age, there are many in the order of 60s, 50s, and 70s, and there is a tendency for elderly people. In the future, colon cancer is expected to increase more and more with the westernization of eating habits and the increasing number of elderly people.

大腸がんは、早期に発見されれば内視鏡切除、外科療法により完治することができる。しかし一般的には自覚症状がないため、検査を定期的に受けない限り、無症状の時期に発見することが困難である。また早期に発見され切除された場合も、再発予防を目的とした補助療法が必要であるが、現在、再発予防効果をもつ有効な抗がん剤がない。このため、手術後は数ヶ月毎に再発チェックの検査を受け、早期に発見するしか手だてがないのが現状である。
特開2002−121132
Colorectal cancer can be completely cured by endoscopic resection and surgical treatment if detected early. However, since there is generally no subjective symptom, it is difficult to detect at the time of asymptomatic unless it is regularly examined. Even if it is detected and resected early, adjuvant therapy aimed at preventing recurrence is necessary, but there is currently no effective anticancer drug having the effect of preventing recurrence. For this reason, the current situation is that after surgery, a relapse check is performed every few months, and it can only be detected early.
JP 2002-121132 A

一つのがん細胞が増殖を繰り返し、がんを発症するまでに通常10年はかかるといわれている。増殖速度が2倍になれば5年で発症するが、逆に10分の1に遅らせることができれば、発症するまでに100年かかり、がんを発症しないまま寿命を全うすることができる。また、がんが発症、転移した場合も同じく、がん細胞の増殖を遅らせることができれば、病気の進行を抑えた状態を保つことができる。本発明は、がん細胞の増殖を遅らせる又は阻止する効果に優れ、長期間使用しても副作用がない安全な細胞休眠剤の提供を目的とし、更には、当該原理を利用した新規な大腸がん予防治療剤の提供を目的とする。   It is said that it usually takes 10 years for one cancer cell to grow and develop cancer. If the growth rate doubles, it will develop in 5 years. Conversely, if it can be delayed by 1/10, it will take 100 years to develop, and the lifespan can be completed without developing cancer. Similarly, when cancer develops or metastasizes, if the growth of cancer cells can be delayed, the progression of the disease can be maintained. An object of the present invention is to provide a safe cell dormant that is excellent in the effect of delaying or inhibiting the growth of cancer cells and has no side effects even when used for a long period of time. The purpose is to provide preventive and therapeutic agents.

本発明者は、米という天然素材を用いた各種製品開発に取り組み、鋭意研究を重ねた結果、米中に含まれる何らかの成分ががん細胞の休眠作用を有すること、及び、大腸がんの予防治療に有効であることを見出し、本発明を完成したものである。   The present inventor has worked on various product development using a natural material called rice, and as a result of intensive research, some components contained in the rice have a dormant action of cancer cells, and prevention of colorectal cancer. The present invention has been completed by finding that it is effective for treatment.

本発明(1)は、米の粉砕物を有効成分として含有するがん細胞休眠剤である。   The present invention (1) is a cancer cell dormant containing a ground rice product as an active ingredient.

本発明(2)は、米の抽出物を有効成分として含有するがん細胞休眠剤である。   The present invention (2) is a cancer cell dormant containing rice extract as an active ingredient.

本発明(3)は、前記抽出物が、米に水又は有機溶媒を加えたもの、米を酸又はアルカリで処理したもの、米の加水物に酵素または麹を作用させたもの、或いは、これらを加熱又は非加熱下でおこなったものである、前記発明(2)のがん細胞休眠剤である。   In the present invention (3), the extract may be obtained by adding water or an organic solvent to rice, treating rice with an acid or an alkali, causing rice hydrolyzate to act on an enzyme or koji, or these Is the cancer cell dormant of the invention (2), which is carried out under heating or non-heating.

本発明(4)は、米を抽出するに際し、その抽出前、抽出と同時又は抽出後に酵素又は麹を作用させたものを有効成分として含有するがん細胞休眠剤である。   The present invention (4) is a cancer cell dormant containing, as an active ingredient, a substance to which an enzyme or koji is acted before, simultaneously with or after extraction of rice.

本発明(5)は、米の抽出物又はそれに酵素若しくは麹を作用させたものに、アルコール発酵又は有機酸発酵を行ったものを有効成分として含有するがん細胞休眠剤である。   The present invention (5) is a cancer cell dormant containing, as an active ingredient, a product obtained by subjecting an extract of rice or an enzyme or koji to the rice extract to alcohol fermentation or organic acid fermentation.

本発明(6)は、前記がん細胞が大腸がんである、前記発明(1)〜(5)のいずれか一つのがん細胞休眠剤である。   The present invention (6) is the cancer cell diapausing agent according to any one of the inventions (1) to (5), wherein the cancer cells are colon cancer.

本発明(7)は、米の粉砕物を有効成分として含有する大腸がん予防治療剤である。   The present invention (7) is a preventive / therapeutic agent for colorectal cancer containing a ground rice product as an active ingredient.

本発明(8)は、米の抽出物を有効成分として含有する大腸がん予防治療剤である。   The present invention (8) is a preventive / therapeutic agent for colorectal cancer containing rice extract as an active ingredient.

本発明(9)は、前記抽出物が、米に水又は有機溶媒を加えたもの、米を酸又はアルカリで処理したもの、米の加水物に酵素または麹を作用させたもの、或いは、これらを加熱又は非加熱下でおこなったものである、前記発明(8)の大腸がん予防治療剤である。   In the present invention (9), the extract may be prepared by adding water or an organic solvent to rice, treating rice with an acid or alkali, allowing rice hydrolyzate to act on an enzyme or koji, or these Is the preventive or therapeutic agent for colorectal cancer according to the invention (8), which is carried out under heating or non-heating.

本発明(10)は、米を抽出するに際し、その抽出前、抽出と同時又は抽出後に酵素又は麹を作用させたものを有効成分として含有する大腸がん予防治療剤である。   The present invention (10) is a preventive / therapeutic agent for colorectal cancer containing, as an active ingredient, a substance to which an enzyme or koji is acted before, simultaneously with or after extraction of rice.

本発明(11)は、米の抽出物又はそれに酵素若しくは麹を作用させたものに、アルコール発酵又は有機酸発酵を行ったものを有効成分として含有する大腸がん予防治療剤である。   The present invention (11) is a colorectal cancer preventive / therapeutic agent containing as an active ingredient a product obtained by subjecting an extract of rice or an enzyme or koji to the rice extract to alcohol fermentation or organic acid fermentation.

ここで、本明細書中の各用語の意義を説明する。「がん細胞休眠剤」とは、がん細胞の増殖を遅らせる又は抑制する作用を有する薬剤を指す。この作用を通じ、がんの発症、進行、転移、再発を阻止することが可能である。また、「がん」の種類は特に限定されず、例えば、大腸がんを挙げることができる。「抽出」とは、物理的処理(例えば、圧搾、加熱処理)、化学的処理(例えば、水又は有機溶媒を添加、酸やアルカリ処理、液体CO処理)、生物的(生化学的)処理(例えば、麹、微生物処理、酵素処理)を単独又は組み合わせて施すことをいう。 Here, the meaning of each term in this specification is explained. The “cancer cell dormant” refers to a drug having an action of delaying or suppressing the growth of cancer cells. Through this action, it is possible to prevent the onset, progression, metastasis, and recurrence of cancer. Moreover, the kind of "cancer" is not specifically limited, For example, colon cancer can be mentioned. “Extraction” means physical treatment (eg, pressing, heat treatment), chemical treatment (eg, addition of water or organic solvent, acid or alkali treatment, liquid CO 2 treatment), biological (biochemical) treatment. (For example, wrinkle, microbial treatment, enzyme treatment) is applied alone or in combination.

以下、本発明を実施するための最良形態について詳述する。尚、本発明の本質は、材料と用途であり、それ以外の要素(例えば、投与量、剤型、作用機序等)は何ら本発明を限定するものではない。   Hereinafter, the best mode for carrying out the present invention will be described in detail. The essence of the present invention is materials and applications, and other elements (for example, dose, dosage form, mechanism of action, etc.) do not limit the present invention.

まず、本発明に係る「米」とは、白米、玄米及び発芽させた米といった米だけでなく、白糠及び赤糠等といった米の一部も含む概念である。但し、白米部分を必須的に含むもの、即ち、白米、玄米、発芽させた米、白糠を用いることが好適である。ここで、白米及び玄米に関しては、ジャポニカ、インディカ米を問わず、うるち米、および餅米等の玄米および白米を指し、品種、種類は問わない。また、白糠及び赤糠とは、一般に、精白時に出てくる92%以上の赤糠や92%以下の白糠を指すが、両者が混合したものを使用してもよい。但し、92%〜50%、80%〜60%、60%〜30%等、92%〜30%のいずれかの白糠を含むものが好適である。なお、有効成分は、熱および光に対して安定であるため、上記の原料は、浸漬、蒸煮、焙煎(砂焙り、網焙り、熱風焙煎等全てを指す)、蒸煮焙煎、凍結乾燥等の表面変性、UV照射等の光変性、パットライス等の加圧焙煎、揚げる等の原料処理をしてもよい。白米、玄米及び発芽させた米は、そのまま用いても有効であるが、実用上の面から粉砕して用いるのが好ましい。白米、玄米及び発芽させた米を粉砕して粉体化するには、粉砕機または精米機を用い一般的な方法で行なえばよい。   First, “rice” according to the present invention is a concept including not only rice such as white rice, brown rice and germinated rice, but also part of rice such as white rice and red rice bran. However, it is preferable to use one that essentially contains a white rice portion, that is, white rice, brown rice, germinated rice, or white birch. Here, with respect to white rice and brown rice, it refers to brown rice and white rice such as glutinous rice and glutinous rice regardless of japonica and indica rice. In addition, white rabbit and red rabbit generally refer to 92% or more red rabbit or 92% or less white rabbit that appears at the time of whitening, but a mixture of both may be used. However, those containing 92% to 30% of white birch, such as 92% to 50%, 80% to 60%, 60% to 30%, etc., are suitable. In addition, since the active ingredient is stable to heat and light, the above-mentioned raw materials are dipping, steaming, roasting (pointing to all of sand roasting, net roasting, hot air roasting, etc.), steaming roasting, freeze drying It may be subjected to raw material treatment such as surface modification such as UV irradiation, photo-modification such as UV irradiation, pressure roasting such as Patrice, frying. White rice, brown rice, and germinated rice are effective when used as they are, but are preferably pulverized for practical use. In order to pulverize white rice, brown rice and germinated rice into powder, a general method may be used using a pulverizer or a rice mill.

発芽させた米を製造する場合、胚芽のついた米を水に浸漬あるいは水を噴霧して発芽させる。発芽させる時の温度は5〜70℃である。ただし、発芽さえすれば、温度および時間は問わない。また、発芽中に水が腐敗する危険性がある場合は、腐敗しないように水を取り替えるか、何らかの防腐を行うのが好ましい。ここで、発芽とは、発芽する直前から発芽したものまで全てを指す。この発芽させた米をよく洗浄して用いる。この時、乾燥して用いてもよい。米を抽出、あるいは酵素分解または麹を作用させる場合、原料の米を粉砕して顆粒あるいは粉体化すると、表面積が大きくなるため効率がよくなる。粉砕しなくてもよいが、この場合には、米組織の分解および抽出に長時間を要する。   In the case of producing germinated rice, germinated rice is immersed in water or sprayed with water. The temperature at the time of germination is 5-70 degreeC. However, the temperature and time are not limited as long as germination occurs. In addition, when there is a risk of water rot during germination, it is preferable to replace the water so that it does not rot or to perform some preservative. Here, germination refers to everything from just before germination to germination. The germinated rice is washed thoroughly before use. At this time, you may dry and use. When rice is extracted, or enzymatically decomposed or subjected to koji, the raw material rice is pulverized into granules or powders, so that the surface area is increased and the efficiency is improved. Although it is not necessary to grind, in this case, it takes a long time to decompose and extract the rice tissue.

米を水抽出する場合、抽出温度は、高温が効率的であるが、低温でも十分に抽出を行うことができる。ただし、40℃以下の低温の場合は、pHを酸性あるいはアルカリ性にするか、防腐剤あるいはアルコールを加えて、米が腐敗しないように処理することが望ましい。抽出時間は、有効成分さえ抽出できれば、長くても短くてもよく、抽出温度により定めればよい。また、抽出は、加圧下または常圧下で行っても、減圧下で行ってもよい。水抽出の場合、最も問題になるのは糊化現象である。糊状になれば、抽出効率が悪くなるばかりでなく、実作業においては困難を極める。これを防ぐためには、アミラーゼを加えて反応させるか、塩酸などで酸性にして澱粉を切ってやればよく、この方法を用いることにより、十分に解決でき、実用上も全く問題はない。   When water is extracted from rice, a high extraction temperature is efficient, but extraction can be sufficiently performed even at a low temperature. However, in the case of a low temperature of 40 ° C. or lower, it is desirable that the pH is made acidic or alkaline, or a preservative or alcohol is added so that the rice is not spoiled. The extraction time may be long or short as long as the active ingredient can be extracted, and may be determined by the extraction temperature. The extraction may be performed under pressure, normal pressure, or reduced pressure. In the case of water extraction, the most serious problem is the gelatinization phenomenon. If it becomes paste-like, not only extraction efficiency will worsen but it will be extremely difficult in actual work. In order to prevent this, amylase may be added and reacted, or the starch may be cut by acidifying with hydrochloric acid or the like. By using this method, the problem can be solved sufficiently and there is no problem in practical use.

抽出物中の有効成分は、酸,アルカリに安定であるためか、酸分解抽出、あるいはアルカリ分解抽出を行うのも有効である。この場合、必要により中和、脱塩を行う。有機溶媒で抽出する場合も、米はなるべく微粉砕または粉体化して抽出することが望ましい。有機溶媒はアルコール,アセトン,n―へキサン,酢酸エチル、メタノール等の一般的な有機溶媒でよいが、人体に対して有害なものは抽出後、溶媒を完全に除去する必要があるので安全なものがよい。また、米を酸素分解、または麹を作用させてもよい。ここで言う酸素分解とは、澱粉分解酵素(液化酵素、糖化酵素),蛋白分解酵素,脂肪分解酵素,繊維分解酵素,リグニン分解酵素,ペクチン分解酵素等米に働く酵素を1種または2種以上作用させることをいう。例えば、液化酵素と糖化酵素との組み合わせを挙げることができる。また、麹として麹菌の種類および米の品種,種類は問わない。なお、酸、アルカリ抽出、有機溶媒抽出、酵素分解、麹作用を組み合わせて行ってもよい。   It is also effective to perform acid decomposition extraction or alkali decomposition extraction because the active ingredient in the extract is stable to acid and alkali. In this case, neutralization and desalting are performed as necessary. Also when extracting with an organic solvent, it is desirable to extract rice by pulverizing or pulverizing it as much as possible. The organic solvent may be a common organic solvent such as alcohol, acetone, n-hexane, ethyl acetate, methanol, etc., but those that are harmful to the human body are safe because the solvent must be completely removed after extraction. Things are good. In addition, rice may be subjected to oxygen decomposition or rice bran. As used herein, oxygen degradation means one or more enzymes that act on rice, such as starch degrading enzymes (liquefaction enzymes, saccharifying enzymes), proteolytic enzymes, lipolytic enzymes, fiber degrading enzymes, lignin degrading enzymes, and pectin degrading enzymes. It means to act. For example, the combination of a liquefying enzyme and a saccharifying enzyme can be mentioned. In addition, the type of koji mold and the variety and type of rice are not questioned. In addition, you may carry out combining acid, alkali extraction, organic-solvent extraction, enzymatic decomposition, and anther effect.

また、前記の抽出を行うに当り、抽出の前、抽出と同時または抽出の後に、上記の酵素分解および麹を作用させてもよい。   In performing the above extraction, the above enzymatic decomposition and soot may be allowed to act before, simultaneously with or after extraction.

更に、上記の処理を行なうと同時または処理後、アルコール発酵あるいは乳酸発酵、酢酸発酵等の有機酸発酵を行ってもよい。特に、有機酸発酵、その中でも乳酸発酵を行なうと、がん細胞休眠効果及び大腸がん予防治療効果が高いことが確認されている。また、アルコール発酵を行なった場合は、濃縮がしやすく、有効成分の濃縮が容易になる。なお、酵母による通気発酵、アルコール沈殿等を行なって除糖してもよい。尚、発酵形態としては、もろみ発酵及び液体発酵のいずれでもよいが、液体発酵が好適である。なお、これらの発酵を2回以上繰り返す、または異なる発酵法を組み合わせてもよい。   Further, organic acid fermentation such as alcohol fermentation, lactic acid fermentation, and acetic acid fermentation may be performed simultaneously with or after the above treatment. In particular, it has been confirmed that when organic acid fermentation, particularly lactic acid fermentation, is performed, cancer cell dormancy effect and colon cancer prevention and treatment effect are high. Moreover, when alcoholic fermentation is performed, it is easy to concentrate and the active ingredient is easily concentrated. Sugar may be removed by aeration fermentation with yeast, alcohol precipitation, or the like. The fermentation form may be moromi fermentation or liquid fermentation, but liquid fermentation is preferred. These fermentations may be repeated twice or more, or different fermentation methods may be combined.

以上のようにして得られた本発明品は、残渣を分離することなくそのまま、あるいは圧搾、濾過して用いる。そのまま用いるときは、殺菌あるいは除菌して製品にする。なお、本発明品は実際の用途に応じ、エアゾール剤、液剤、ゼリー剤、エリキシル剤、カプセル剤、顆粒剤、丸剤、懸濁剤、乳剤、散剤、細粒剤、錠剤、シロップ剤、注射剤、トローチ剤、リモナーデ剤等の剤型で用いることもできる。更には、食品や飲料に添加する処方もあり得る。なお、用途に応じて、他の配合成分や薬剤を添加してもよい。尚、本発明品の添加量は、添加対象となる医薬品、飲食品等の種類にもよるが、一般的に、製品100重量部当たり、本発明品エキスを0.0001〜90重量部、好適には0.01〜60重量部、最も好適には0.1〜30重量部添加する。また、本発明品の摂取量は、体重1kg当たり、一日0.0001〜100ml、好適には一日0.001〜50ml、最も好適には0.01〜20mlである。   The product of the present invention obtained as described above is used as it is, or after being squeezed and filtered without separating the residue. When it is used as it is, it is sterilized or sterilized to make a product. The product of the present invention is aerosol, liquid, jelly, elixir, capsule, granule, pill, suspension, emulsion, powder, fine granule, tablet, syrup, injection depending on the actual application. It can also be used in dosage forms such as agents, troches, and limonades. Furthermore, there may be a prescription added to foods and beverages. In addition, you may add another compounding component and a chemical | medical agent according to a use. In addition, although the addition amount of the product of the present invention depends on the kind of the drug to be added, food and drink, etc., generally 0.0001 to 90 parts by weight of the product extract of the present invention per 100 parts by weight of the product is preferable. Is added in an amount of 0.01 to 60 parts by weight, most preferably 0.1 to 30 parts by weight. The intake of the product of the present invention is 0.0001 to 100 ml per day, preferably 0.001 to 50 ml, most preferably 0.01 to 20 ml per kg body weight.

尚、実際の製品との関係では、例えば、がん細胞休眠剤又は大腸がん予防治療剤である旨の表示を直接又は間接的に付することが好適である。該表示を付する対象としては、製品(例えば、薬剤、特定保健用食品、病者用食品、健康食品、飲食品)のパッケージ、パンフレット、取扱説明書等を挙げることができる。このような表示を付することにより、本発明品がそのような効果を奏することが、ユーザに一目瞭然となる。ここで、「がん細胞休眠剤である旨の表示」又は「大腸がん予防治療剤である旨の表示」とは、これらを明記した場合のみならず、これらを示唆する表示も包含する。   In relation to the actual product, for example, it is preferable to display directly or indirectly a label indicating that it is a cancer cell dormant or a colorectal cancer preventive or therapeutic agent. Examples of objects to which the label is attached include packages of products (for example, drugs, foods for specified health use, foods for patients, health foods, foods and drinks), pamphlets, instruction manuals, and the like. By attaching such a display, it is obvious to the user that the product of the present invention has such an effect. Here, the “indication that it is a cancer cell dormant” or the “indication that it is a colorectal cancer preventive / therapeutic agent” includes not only the case where these are specified, but also the indication suggesting them.

実施例1
白米を粉砕機にかけ、白米の粉砕物1kgを得た。この粉砕物に液化酵素5gと水3Lを添加し、60℃で4時間放置した。その後、加熱昇温させ、冷却した後、濾過器を用いて固液分離を行い、ろ液2.5Lを得た。これを85℃で30分加熱して本発明品を得た。
Example 1
The white rice was put into a grinder to obtain 1 kg of white rice grind. To this pulverized product, 5 g of liquefied enzyme and 3 L of water were added and left at 60 ° C. for 4 hours. Then, after heating up and cooling, solid-liquid separation was performed using the filter and 2.5 L of filtrate was obtained. This was heated at 85 ° C. for 30 minutes to obtain the product of the present invention.

実施例2
白米を粉砕機にかけ、白米の粉砕物1kgを得た。この粉砕物に麹250gと水3Lを添加し、55℃で16時間放置した。その後濾過器を用いて固液分離を行い、ろ液2.6Lを得た。これを85℃で30分加熱して本発明品を得た。
Example 2
White rice was ground in a grinder to obtain 1 kg of white rice grind. To this pulverized product, 250 g of candy and 3 L of water were added and left at 55 ° C. for 16 hours. Thereafter, solid-liquid separation was performed using a filter to obtain 2.6 L of a filtrate. This was heated at 85 ° C. for 30 minutes to obtain the product of the present invention.

実施例3
白米を粉砕機にかけ、白米の粉砕物1kgを得た。この粉砕物に澱粉分解酵素5gと水3Lを添加し、55℃で16時間放置した。その後濾過器を用いて固液分離を行い、ろ液2.5Lを得た。これを85℃で30分加熱して本発明品を得た。
Example 3
White rice was ground in a grinder to obtain 1 kg of white rice grind. To this pulverized product, 5 g of starch-degrading enzyme and 3 L of water were added and left at 55 ° C. for 16 hours. Thereafter, solid-liquid separation was performed using a filter to obtain 2.5 L of a filtrate. This was heated at 85 ° C. for 30 minutes to obtain the product of the present invention.

実施例4
白米を粉砕機にかけ、白米の粉砕物1kgを得た。この粉砕物に繊維分解酵素5gと水3Lを添加し、50℃で16時間放置した。その後濾過器を用いて固液分離を行い、ろ液2.0Lを得た。これを85℃で30分加熱して本発明品を得た。
Example 4
White rice was ground in a grinder to obtain 1 kg of white rice grind. To this pulverized product, 5 g of a fiber-degrading enzyme and 3 L of water were added and left at 50 ° C. for 16 hours. Thereafter, solid-liquid separation was performed using a filter to obtain 2.0 L of a filtrate. This was heated at 85 ° C. for 30 minutes to obtain the product of the present invention.

実施例5
白米を粉砕機にかけ、白米の粉砕物1kgを得た。この粉砕物に液化酵素5gと水3Lを添加し、60℃で4時間放置した。その後、加熱昇温させ、冷却した後、澱粉分解酵素5gを加え、55℃で4時間放置した。その後濾過器を用いて固液分離を行い、ろ液2.6Lを得た。これを85℃で30分加熱して本発明品を得た。
Example 5
White rice was ground in a grinder to obtain 1 kg of white rice grind. To this pulverized product, 5 g of liquefied enzyme and 3 L of water were added and left at 60 ° C. for 4 hours. Thereafter, the temperature was raised by heating, and after cooling, 5 g of amylolytic enzyme was added and left at 55 ° C. for 4 hours. Thereafter, solid-liquid separation was performed using a filter to obtain 2.6 L of a filtrate. This was heated at 85 ° C. for 30 minutes to obtain the product of the present invention.

実施例6
白米を粉砕機にかけ、白米の粉砕物1kgを得た。この粉砕物に液化酵素5gと水3Lを添加し、60℃で4時間放置した。その後、加熱昇温させ、冷却した後、蛋白質分解酵素5gを加え、55℃で4時間放置した。その後濾過器を用いて固液分離を行い、ろ液2.5Lを得た。これを85℃で30分加熱して本発明品を得た。
Example 6
White rice was ground in a grinder to obtain 1 kg of white rice grind. To this pulverized product, 5 g of liquefied enzyme and 3 L of water were added and left at 60 ° C. for 4 hours. Then, after heating up and cooling, 5 g of proteolytic enzymes were added and left at 55 ° C. for 4 hours. Thereafter, solid-liquid separation was performed using a filter to obtain 2.5 L of a filtrate. This was heated at 85 ° C. for 30 minutes to obtain the product of the present invention.

実施例7
白米を粉砕機にかけ、白米の粉砕物1kgを得た。この粉砕物に、蛋白質分解酵素5g、脂肪分解酵素5g、繊維分解酵素5g、澱粉分解酵素5g、ペクチン分解酵素5gと水3Lを加え、50℃で20時間放置した。その後、徐々に温度を上げていき、5分間煮沸抽出した後、30℃まで冷却し、絞り機で絞り、本発明品2.6Lを得た。
Example 7
White rice was ground in a grinder to obtain 1 kg of white rice grind. To this pulverized product, 5 g of proteolytic enzyme, 5 g of lipolytic enzyme, 5 g of fiber degrading enzyme, 5 g of starch degrading enzyme, 5 g of pectin degrading enzyme and 3 L of water were added and left at 50 ° C. for 20 hours. Thereafter, the temperature was gradually raised, boiling and extracted for 5 minutes, cooled to 30 ° C., and squeezed with a squeezer to obtain 2.6 L of the present invention product.

実施例8
精白歩合30〜60%の白糠1kgに液化酵素5gと水3Lを添加し、60℃で4時間放置した。その後、加熱昇温させ、冷却した後、澱粉分解酵素5gを加え、55℃で4時間放置した。その後濾過器を用いて固液分離を行い、ろ液2.4Lを得た。これを85℃で30分加熱して本発明品を得た。
Example 8
5 g of liquefied enzyme and 3 L of water were added to 1 kg of white lees with a polishing rate of 30 to 60% and left at 60 ° C. for 4 hours. Thereafter, the temperature was raised by heating, and after cooling, 5 g of amylolytic enzyme was added and left at 55 ° C. for 4 hours. Thereafter, solid-liquid separation was performed using a filter to obtain 2.4 L of a filtrate. This was heated at 85 ° C. for 30 minutes to obtain the product of the present invention.

実施例9
精白歩合60〜80%の白糠1kgに液化酵素5gと水3Lを添加し、60℃で4時間放置した。その後、加熱昇温させ、冷却した後、澱粉分解酵素5gを加え、55℃で4時間放置した。その後濾過器を用いて固液分離を行い、ろ液2.4Lを得た。これを85℃で30分加熱して本発明品を得た。
Example 9
5 g of liquefied enzyme and 3 L of water were added to 1 kg of white lees with a whitening ratio of 60 to 80%, and left at 60 ° C. for 4 hours. Thereafter, the temperature was raised by heating, and after cooling, 5 g of amylolytic enzyme was added and left at 55 ° C. for 4 hours. Thereafter, solid-liquid separation was performed using a filter to obtain 2.4 L of a filtrate. This was heated at 85 ° C. for 30 minutes to obtain the product of the present invention.

実施例10
精白歩合50〜92%の白糠1kgに液化酵素5gと水3Lを添加し、60℃で4時間放置した。その後、加熱昇温させ、冷却した後、澱粉分解酵素5gを加え、55℃で4時間放置した。その後濾過器を用いて固液分離を行い、ろ液2.3Lを得た。これを85℃で30分加熱して本発明品を得た。
Example 10
5 g of liquefied enzyme and 3 L of water were added to 1 kg of white candy with a whitening ratio of 50 to 92% and left at 60 ° C. for 4 hours. Thereafter, the temperature was raised by heating, and after cooling, 5 g of amylolytic enzyme was added and left at 55 ° C. for 4 hours. Thereafter, solid-liquid separation was performed using a filter to obtain 2.3 L of a filtrate. This was heated at 85 ° C. for 30 minutes to obtain the product of the present invention.

実施例11
精白歩合30〜92%の白糠1kgに液化酵素5gと水3Lを添加し、60℃で4時間放置した。その後、加熱昇温させ、冷却した後、澱粉分解酵素5gを加え、55℃で4時間放置した。その後濾過器を用いて固液分離を行い、ろ液2.5Lを得た。これを85℃で30分加熱して本発明品を得た。
Example 11
5 g of liquefied enzyme and 3 L of water were added to 1 kg of white candy with a polishing rate of 30 to 92%, and the mixture was allowed to stand at 60 ° C. for 4 hours. Thereafter, the temperature was raised by heating, and after cooling, 5 g of amylolytic enzyme was added and left at 55 ° C. for 4 hours. Thereafter, solid-liquid separation was performed using a filter to obtain 2.5 L of a filtrate. This was heated at 85 ° C. for 30 minutes to obtain the product of the present invention.

実施例12
精白歩合50〜70%の白糠490g、92%以上の赤糠10gに、蛋白質分解酵素2g、脂肪分解酵素2g、繊維分解酵素2g、澱粉分解酵素2g、ペクチン分解酵素2gと水1.5Lを加え、50℃で20時間放置した。その後、徐々に温度を上げていき、5分間煮沸抽出した後、30℃まで冷却し、絞り機で絞り、本発明品1.2Lを得た。
Example 12
To 490 g of white koji with a whitening ratio of 50-70% and 10 g of red koji over 92%, add 2 g of proteolytic enzyme, 2 g of lipolytic enzyme, 2 g of fiber degrading enzyme, 2 g of starch degrading enzyme, 2 g of pectin degrading enzyme and 1.5 L of water And left at 50 ° C. for 20 hours. Thereafter, the temperature was gradually raised, boiling and extracted for 5 minutes, cooled to 30 ° C., and squeezed with a squeezer to obtain 1.2 L of the present invention product.

実施例13
玄米を粉砕機にかけ、玄米の粉砕物500gを得た。この粉砕物に、蛋白質分解酵素2g、脂肪分解酵素2g、繊維分解酵素2g、澱粉分解酵素2g、ペクチン分解酵素2gと水1.5Lを加え、50℃で20時間放置した。その後、徐々に温度を上げていき、5分間煮沸抽出した後、30℃まで冷却し、絞り機で絞り、本発明品2.2Lを得た。
Example 13
Brown rice was put into a pulverizer to obtain 500 g of pulverized brown rice. To this pulverized product, 2 g of proteolytic enzyme, 2 g of lipolytic enzyme, 2 g of fiber degrading enzyme, 2 g of starch degrading enzyme, 2 g of pectin degrading enzyme and 1.5 L of water were added and left at 50 ° C. for 20 hours. Thereafter, the temperature was gradually raised, boiling and extracted for 5 minutes, then cooled to 30 ° C., and squeezed with a squeezer to obtain 2.2 L of the present invention.

実施例14
胚芽のついたままの米1kgを30℃の水につけ3日間浸漬、吸水させ、米を発芽させた。この発芽米をよく洗浄した後、50℃で24時間乾燥し、その後細かく微粉砕し、発芽米の粉砕物を得た。この発芽米粉砕物500gに、蛋白質分解酵素2g、脂肪分解酵素2g、繊維分解酵素2g、澱粉分解酵素2g、ペクチン分解酵素2gと水1.5Lを加え、50℃で20時間放置した。その後、徐々に温度を上げていき、5分間煮沸抽出した後、30℃まで冷却し、絞り機で絞り、本発明品1.1Lを得た。
Example 14
1 kg of rice with germs attached was soaked in water at 30 ° C. for 3 days to absorb water and germinate the rice. The germinated rice was thoroughly washed, dried at 50 ° C. for 24 hours, and then finely pulverized to obtain a pulverized product of germinated rice. To 500 g of the pulverized rice flour, 2 g of proteolytic enzyme, 2 g of lipolytic enzyme, 2 g of fiber degrading enzyme, 2 g of starch degrading enzyme, 2 g of pectin degrading enzyme and 1.5 L of water were added and left at 50 ° C. for 20 hours. Thereafter, the temperature was gradually raised, boiling and extracted for 5 minutes, then cooled to 30 ° C., and squeezed with a squeezer to obtain 1.1 L of the present product.

実施例15
白米を粉砕機にかけ、白米の粉砕物1kgを得た。この粉砕物に1/10N塩酸3Lを添加し、よく撹拌し24時間放置した。その後、濾過器を用いて固液分離を行い、苛性ソーダで中和し、2.3Lの抽出液を得た。これを85℃で30分加熱して本発明品を得た。
Example 15
White rice was ground in a grinder to obtain 1 kg of white rice grind. To this pulverized product, 3 L of 1 / 10N hydrochloric acid was added, stirred well and allowed to stand for 24 hours. Thereafter, solid-liquid separation was performed using a filter and neutralized with caustic soda to obtain 2.3 L of an extract. This was heated at 85 ° C. for 30 minutes to obtain the product of the present invention.

実施例16
白米を粉砕機にかけ、白米の粉砕物1kgを得た。この粉砕物に95%エタノール3Lを添加し、よく撹拌し4日間放置した。その後、濾過器を用いて固液分離を行い、2Lの抽出液を得た。このろ液に水4Lを加え、ロータリーエバポレーターでエタノールを留去し2Lとした。これを85℃で30分加熱して本発明品を得た。
Example 16
White rice was ground in a grinder to obtain 1 kg of white rice grind. To this pulverized product, 3 L of 95% ethanol was added, stirred well and left for 4 days. Thereafter, solid-liquid separation was performed using a filter to obtain a 2 L extract. 4 L of water was added to the filtrate, and ethanol was distilled off with a rotary evaporator to 2 L. This was heated at 85 ° C. for 30 minutes to obtain the product of the present invention.

実施例17
白米を粉砕機にかけ、白米の粉砕物1kgを得た。この粉砕物に液化酵素5gと水3Lを添加し、60℃で4時間放置した。その後、加熱昇温させ、冷却した後、澱粉分解酵素5gを加え、55℃で4時間放置し、加熱殺菌、冷却後乳酸菌を加え、37℃で2日間発酵を行った。これを、絞り機で絞り、固液分離し、85℃で30分加熱して本発明品を得た。
Example 17
White rice was ground in a grinder to obtain 1 kg of white rice grind. To this pulverized product, 5 g of liquefied enzyme and 3 L of water were added and left at 60 ° C. for 4 hours. Then, after heating and heating and cooling, 5 g of starch-degrading enzyme was added and allowed to stand at 55 ° C. for 4 hours. After heat sterilization and cooling, lactic acid bacteria were added, and fermentation was performed at 37 ° C. for 2 days. This was squeezed with a squeezer, separated into solid and liquid, and heated at 85 ° C. for 30 minutes to obtain the product of the present invention.

実施例18
実施例1で得られた液2.5Lを加熱殺菌し、冷却後乳酸菌を加え、37℃で2日間発酵を行った。その後濾過器を用いてろ過を行い、85℃で30分加熱して本発明品2.4Lを得た。
Example 18
The liquid 2.5L obtained in Example 1 was sterilized by heating, and after cooling, lactic acid bacteria were added, followed by fermentation at 37 ° C. for 2 days. Thereafter, the mixture was filtered using a filter and heated at 85 ° C. for 30 minutes to obtain 2.4 L of the present product.

実施例19
実施例7で得られた液2.6Lに、酵母を加え、15日間発酵を行った。その後濾過器を用いてろ過を行い、85℃で30分加熱して本発明品2.5Lを得た。
Example 19
Yeast was added to 2.6 L of the liquid obtained in Example 7, and fermentation was performed for 15 days. Thereafter, the mixture was filtered using a filter and heated at 85 ° C. for 30 minutes to obtain 2.5 L of the present product.

実施例20
実施例11で得られたろ液2.5Lに、95%エタノール150mLと酢酸菌を加え、20日間酢酸発酵を行った。その後濾過器を用いてろ過を行い、85℃で30分加熱して本発明品2.4Lを得た。
Example 20
To 2.5 L of the filtrate obtained in Example 11, 150 mL of 95% ethanol and acetic acid bacteria were added, and acetic acid fermentation was performed for 20 days. Thereafter, the mixture was filtered using a filter and heated at 85 ° C. for 30 minutes to obtain 2.4 L of the present product.

試験例1
方法:ヒト大腸癌粘膜細胞HCT116株を用いて1×10個に播種し、培地中に原液の10-1濃度の各試料を添加後72時間培養し、その増殖を観察した。コントロールは、ヒト大腸癌粘膜細胞HCT116株を用いて1×10個に播種し、試料を添加していない培地で72時間培養した。
試料:実施例1〜7、9、11及び15〜20
結果:図1に、コントロールと試料の代表例として実施例18の培養72時間後の大腸癌粘膜細胞HCT116を示した。コントロールの大腸癌粘膜細胞HCT116では、培養72時間後に分裂細胞が観察された。一方、実施例1〜7、9、11及び15〜20を10-1の濃度で培養液中に添加した大腸癌粘膜細胞HCT116では、培養72時間後に分裂細胞が観察されず、がん細胞の増殖阻止作用が認められた。この結果、本発明は大腸癌予防治療効果をもつことが判明した。また、がん細胞の増殖を遅らせる又は抑制する作用を有し、この作用を通じ、がんの発症、進行、転移、再発を阻止することが判明した。
Test example 1
Method: 1 × 10 5 human colon cancer mucosal cell HCT116 strain was seeded, and each sample having a concentration of 10 −1 of the stock solution was added to the medium and cultured for 72 hours, and its growth was observed. As a control, 1 × 10 5 cells were inoculated using human colon cancer mucosal cell line HCT116 and cultured for 72 hours in a medium to which no sample was added.
Sample: Examples 1-7, 9, 11, and 15-20
Results: FIG. 1 shows colon cancer mucosa cells HCT116 after 72 hours of culture in Example 18 as a representative example of control and sample. In control colon cancer mucosal cells HCT116, dividing cells were observed after 72 hours of culture. On the other hand, in colon cancer mucosal cells HCT116 in which Examples 1 to 7, 9, 11, and 15 to 20 were added to the culture solution at a concentration of 10 −1 , dividing cells were not observed after 72 hours of culturing. Antiproliferative action was observed. As a result, it was found that the present invention has an effect of preventing and treating colorectal cancer. It has also been found to have an action of delaying or suppressing the growth of cancer cells, and through this action, the onset, progression, metastasis, and recurrence of cancer are prevented.

試験例2
方法:ヒト大腸癌粘膜細胞HCT116株を用いて、培地中に原液の10-1濃度の各試料を添加後24時間培養し、BrdUの取り込みを定量化しDNAの合成をELISA法を用い測定した。コントロールは、ヒト大腸癌粘膜細胞HCT116株を用いて、試料を添加していない培地で24時間培養した。
試料:実施例1〜7、9、11及び15〜20
結果:実施例1〜7、9、11及び15〜20を添加することにより、コントロールと比較してヒト大腸癌粘膜細胞のDNA合成が有意に抑制された(図2)。この結果、本発明はがん細胞のDNA合成を抑制することによりがん細胞の増殖を阻止することが判明した。特に、液化酵素を用いた実施例(実施例1、5、6、9、11、17及び20)と乳酸発酵を行なった実施例(実施例17及び18)の効果が顕著であることが分かる。
Test example 2
Method: Human colorectal cancer mucosal cell line HCT116 was used, and each sample having a stock concentration of 10 −1 was added to the medium and cultured for 24 hours. The BrdU incorporation was quantified, and DNA synthesis was measured using ELISA. As a control, human colon cancer mucosal cell line HCT116 was used and cultured for 24 hours in a medium to which no sample was added.
Sample: Examples 1-7, 9, 11, and 15-20
Results: By adding Examples 1-7, 9, 11, and 15-20, the DNA synthesis | combination of the human colon cancer mucosa cell was significantly suppressed compared with control (FIG. 2). As a result, it has been found that the present invention inhibits the growth of cancer cells by suppressing the DNA synthesis of the cancer cells. In particular, it can be seen that the effects of the examples using liquefaction enzymes (Examples 1, 5, 6, 9, 11, 17 and 20) and the examples of performing lactic acid fermentation (Examples 17 and 18) are remarkable. .

試験例3
方法:ヒト大腸癌粘膜細胞HCT116株を用いて、培地中に原液の10-1濃度の各試料を添加後24時間培養し、培養上清中のLDHを測定することにより細胞傷害作用を定量化した。コントロールは、ヒト大腸癌粘膜細胞HCT116株を用いて、試料を添加していない培地で24時間培養した。
試料:実施例1〜7、9、11及び15〜20
結果:上清中のLDHを測定した結果、実施例1〜7、9、11及び15〜20を添加したものと、コントロールに有意な差は認められなかった(図3)。この結果、本発明のがん細胞増殖阻止効果は、細胞障害作用によるものではないことが判明した。
Test example 3
Method: Using human colon cancer mucosal cell line HCT116, culturing for 24 hours after adding each sample at 10 -1 concentration of the stock solution in the medium, and quantifying cytotoxicity by measuring LDH in the culture supernatant did. As a control, human colon cancer mucosal cell line HCT116 was used and cultured for 24 hours in a medium to which no sample was added.
Sample: Examples 1-7, 9, 11, and 15-20
Results: As a result of measuring LDH in the supernatant, no significant difference was observed between the controls in which Examples 1 to 7, 9, 11, and 15 to 20 were added (FIG. 3). As a result, it has been found that the cancer cell proliferation inhibitory effect of the present invention is not due to cytotoxicity.

図1は、試験例1において、コントロール(A)と実施例18(B)を添加した際の、培養72時間後の大腸癌粘膜細胞HCT116を撮影した写真である。FIG. 1 is a photograph of colon cancer mucosal cells HCT116 taken 72 hours after culture when Control (A) and Example 18 (B) were added in Test Example 1. 図2は、試験例2において、コントロールと実施例1〜7、9、11及び15〜20を添加した際の、ヒト大腸癌粘膜細胞のDNA合成量を示した図である。FIG. 2 is a graph showing the amount of DNA synthesized in human colon cancer mucosal cells when Test and Examples 1 to 7, 9, 11, and 15 to 20 were added in Test Example 2. 図3は、試験例3において、コントロールと実施例1〜7、9、11及び15〜20を添加した際の、培養上清中のLDH活性を示した図である。FIG. 3 is a diagram showing LDH activity in the culture supernatant when Control and Examples 1 to 7, 9, 11, and 15 to 20 were added in Test Example 3.

Claims (21)

白米の粉砕物を有効成分として含有する、大腸癌細胞の増殖抑制剤。 A colon cancer cell growth inhibitor comprising pulverized white rice as an active ingredient . 白米の抽出物を有効成分として含有する、大腸癌細胞の増殖抑制剤。 A colon cancer cell growth inhibitor comprising a white rice extract as an active ingredient . 前記抽出物が、白米に水又は有機溶媒を加えたもの、白米を酸又はアルカリで処理したもの、白米の加水物に酵素または麹を作用させたもの、或いは、これらを加熱又は非加熱下でおこなったものである、請求項2記載の剤。 The extract is obtained by adding water or an organic solvent to white rice, processed white rice with acid or alkali, processed white rice hydrolyzate with enzyme or koji, or heated or unheated. The agent according to claim 2, which has been performed . 白米を抽出するに際し、その抽出前、抽出と同時又は抽出後に酵素又は麹を作用させたものを有効成分として含有する、大腸癌細胞の増殖抑制剤。 An agent for inhibiting the growth of colorectal cancer cells, which contains , as an active ingredient, an enzyme or koji that acts upon extraction of white rice before, simultaneously with or after extraction . 白米の抽出物又はそれに酵素若しくは麹を作用させたものに、アルコール発酵又は有機酸発酵を行ったものを有効成分として含有する、大腸癌細胞の増殖抑制剤。 A colon cancer cell growth inhibitor comprising, as an active ingredient, a white rice extract or a product obtained by subjecting an extract or a rice cake to alcohol or organic acid fermentation . 白米を原料とした液化酵素処理物を有効成分として含有する、大腸癌細胞の増殖抑制剤。 A colon cancer cell growth inhibitor comprising, as an active ingredient, a liquefied enzyme-treated product made from white rice . 白米を原料とした乳酸発酵処理物を有効成分として含有する、大腸癌細胞の増殖抑制剤。 A growth inhibitor of colorectal cancer cells, which contains , as an active ingredient, a lactic acid fermentation product made from white rice . 白米の粉砕物を有効成分として含有する、大腸癌細胞のDNA合成抑制剤。 A DNA synthesis inhibitor for colorectal cancer cells, comprising a milled white rice product as an active ingredient . 白米の抽出物を有効成分として含有する、大腸癌細胞のDNA合成抑制剤。 A DNA synthesis inhibitor for colorectal cancer cells, comprising an extract of white rice as an active ingredient . 前記抽出物が、白米に水又は有機溶媒を加えたもの、白米を酸又はアルカリで処理したもの、白米の加水物に酵素または麹を作用させたもの、或いは、これらを加熱又は非加熱下でおこなったものである、請求項9記載の剤。 The extract is obtained by adding water or an organic solvent to white rice, processed white rice with acid or alkali, processed white rice hydrolyzate with enzyme or koji, or heated or unheated. The agent according to claim 9, which has been performed . 白米を抽出するに際し、その抽出前、抽出と同時又は抽出後に酵素又は麹を作用させたものを有効成分として含有する、大腸癌細胞のDNA合成抑制剤。 An agent for inhibiting DNA synthesis of colon cancer cells, containing , as an active ingredient, an enzyme or koji that acts upon extraction of white rice before, simultaneously with or after extraction . 白米の抽出物又はそれに酵素若しくは麹を作用させたものに、アルコール発酵又は有機酸発酵を行ったものを有効成分として含有する、大腸癌細胞のDNA合成抑制剤。 A colon cancer cell DNA synthesis inhibitor comprising, as an active ingredient, an extract of white rice or an enzyme or koji that has been subjected to alcohol fermentation or organic acid fermentation . 白米を原料とした液化酵素処理物を有効成分として含有する、大腸癌細胞のDNA合成抑制剤。 A DNA synthesis inhibitor for colon cancer cells, containing as an active ingredient a liquefied enzyme-treated product made from white rice . 白米を原料とした乳酸発酵処理物を有効成分として含有する、大腸癌細胞のDNA合成抑制剤。 A DNA synthesis inhibitor for colorectal cancer cells, which contains , as an active ingredient, a lactic acid fermentation product made from white rice . 白米の粉砕物を有効成分として含有する、大腸癌細胞の細胞障害作用剤。  A cytotoxic agent for colorectal cancer cells, comprising a milled product of white rice as an active ingredient. 白米の抽出物を有効成分として含有する、大腸癌細胞の細胞障害作用剤。  A cytotoxic agent for colorectal cancer cells, comprising an extract of white rice as an active ingredient. 前記抽出物が、白米に水又は有機溶媒を加えたもの、白米を酸又はアルカリで処理したもの、白米の加水物に酵素または麹を作用させたもの、或いは、これらを加熱又は非加熱下でおこなったものである、請求項16記載の剤。  The extract is obtained by adding water or an organic solvent to white rice, processed white rice with acid or alkali, processed white rice hydrolyzate with enzyme or koji, or heated or unheated. The agent according to claim 16, which has been performed. 白米を抽出するに際し、その抽出前、抽出と同時又は抽出後に酵素又は麹を作用させたものを有効成分として含有する、大腸癌細胞の細胞障害作用剤。  A cytotoxic agent for colorectal cancer cells, which contains, as an active ingredient, an enzyme or koji that acts upon extraction of white rice before, simultaneously with or after extraction. 白米の抽出物又はそれに酵素若しくは麹を作用させたものに、アルコール発酵又は有機酸発酵を行ったものを有効成分として含有する、大腸癌細胞の細胞障害作用剤。  A cytotoxic agent for colorectal cancer cells, comprising, as an active ingredient, an extract of white rice or an enzyme or koji that has been subjected to alcohol fermentation or organic acid fermentation. 白米を原料とした液化酵素処理物を有効成分として含有する、大腸癌細胞の細胞障害作用剤。  A cytotoxic agent for colorectal cancer cells, comprising as an active ingredient a liquefied enzyme-treated product made from white rice. 白米を原料とした乳酸発酵処理物を有効成分として含有する、大腸癌細胞の細胞障害作用剤。  A cytotoxic agent for colorectal cancer cells, which contains, as an active ingredient, a lactic acid fermentation product made from white rice.
JP2004306087A 2004-10-20 2004-10-20 Cancer cell dormant Active JP5102432B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2004306087A JP5102432B2 (en) 2004-10-20 2004-10-20 Cancer cell dormant

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004306087A JP5102432B2 (en) 2004-10-20 2004-10-20 Cancer cell dormant

Publications (2)

Publication Number Publication Date
JP2006117575A JP2006117575A (en) 2006-05-11
JP5102432B2 true JP5102432B2 (en) 2012-12-19

Family

ID=36535809

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004306087A Active JP5102432B2 (en) 2004-10-20 2004-10-20 Cancer cell dormant

Country Status (1)

Country Link
JP (1) JP5102432B2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5295312B2 (en) * 2011-06-10 2013-09-18 暁酵素産業株式会社 Liquid composition for cancer prevention and method for producing the same
US20220040131A1 (en) * 2018-09-19 2022-02-10 Nihon Sizen Hakkoh Co., Ltd. Prophylactic agent for spontaneous cancers
JP7209194B2 (en) * 2018-09-21 2023-01-20 株式会社日本自然発酵 immune checkpoint inhibitor
JPWO2022003749A1 (en) * 2020-06-29 2022-01-06

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2787252B2 (en) * 1991-06-17 1998-08-13 雪印乳業株式会社 Colorectal cancer inhibitor
JPH06298660A (en) * 1993-02-19 1994-10-25 Soken Kk Preventive and therapeutic medicine for cancer produced from rice
JPH06293656A (en) * 1993-04-07 1994-10-21 Soken Kk Cancer preventing and treating agent derived from rice
JP3779739B2 (en) * 1993-12-06 2006-05-31 株式会社創研 Salt damage inhibitor from rice
JP2002138046A (en) * 2000-10-30 2002-05-14 Toyo Shinyaku:Kk Nk cell activator
JP2002316940A (en) * 2001-04-20 2002-10-31 Oriza Yuka Kk Colon cancer-preventing agent
JP2003342188A (en) * 2002-05-29 2003-12-03 Sakamoto Jozo Kk Anticancer agent

Also Published As

Publication number Publication date
JP2006117575A (en) 2006-05-11

Similar Documents

Publication Publication Date Title
CN108347974B (en) Bacillus amyloliquefaciens strain, grain fermentation product, preparation method and application thereof
CN109105736B (en) Method for producing grain fermentation enzyme powder with increased fermentation efficiency using liquid seed culture fluid inoculated with Bacillus coagulans strain
JP2018531036A6 (en) New strain derived from traditional fermented food with excellent enzyme-producing ability and method for producing cereal fermented enzyme food using the same
KR101613692B1 (en) Method for Preparing Brown Rice Bran with Decreased Glycemic Index
CN103315305B (en) Rice cake composition containing fish scale collagen and edible plants extract and vermicelli composition
KR20200076157A (en) Composition for improving, treating or preventing intestinal function or inflammarory bowel disease comprising fermented rice as an active ingredient
KR20120051616A (en) Functional pear fermented liquid using by-product of pear processing and its application method
JP5102432B2 (en) Cancer cell dormant
JP5484913B2 (en) Insoluble dietary fiber-containing substances derived from cereal plant seeds
JP2010100663A (en) Enzyme inhibitor containing fermentation product of allium cepa l
JP5372656B2 (en) Metabolic syndrome improving composition
US5728384A (en) Antiulcer agent
WO2002071873A1 (en) Functional cereals
JP4524022B2 (en) α-Amylase inhibitor
JP2011000055A (en) Composition for lasting feeling of fullness, containing insoluble dietary fiber derived from grain plant seed
JP6181914B2 (en) Ceramide production promoter
JP2670742B2 (en) α-amylase inhibitor
EP3542811B1 (en) Black rice sprouting liquid having anti-inflammatory effect and manufacturing method thereof
Tian et al. Research progress of quality characteristics and comprehensive utilization of mung beans
JP5668018B2 (en) Alcohol intake disorder preventive
JP6533478B2 (en) Whitening agent and internal or external composition containing the same
JP3779739B2 (en) Salt damage inhibitor from rice
JP2014237693A (en) Whitening agent and internal or external composition comprising the same
KR20190118057A (en) Manufacturing method of brown rice-seaweed composition fermented aspergillus
KR102338680B1 (en) Method for manufacturing functional mugwort and brown rice cake

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20071004

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110125

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20111101

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20111222

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20120904

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20120928

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20151005

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Ref document number: 5102432

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250